Deep learning discerns cancer mutation exclusivity
Gupta, P.; Jindal, A.; Jayadeva, J.; Sengupta, D.
Show abstract
The exclusivity of a vast majority of cancer mutations remains poorly understood, despite the availability of large amounts of whole genome and exome sequencing data. In clinical settings, this markedly hinders the identification of the previously uncharacterized deleterious mutations due to the unavailability of matched normal samples. We employed state of the art deep learning algorithms for cross-exome learning of mutational embeddings and demonstrated their utility in sequence based detection of cancer-specific Single Nucleotide Variants (SNVs).
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- A pan-cancer landscape of somatic substitutions in non-unique regions of the human genome 97%
- Haplotype-enhanced inference of somatic copy number profiles from single-cell transcriptomes 95%
- Characterizing the allele- and haplotype-specific copy number landscape of cancer genomes at single-cell resolution with CHISEL 94%
Similar papers in this journal
- Fast Fourier Transform is a training-free, ultrafast, highly efficient, and fully interpretable approach for epigenomic data compression 95%
- Functional buffering via cell-specific gene expression promotes tissue homeostasis and cancer robustness 94%
- Interpretable Deep Learning for Improving Cancer Patient Survival Based on Personal Transcriptomes 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.